This step chart displays the nominal dividend payouts over time by ex-dividend date (the date you must own the stock by to receive each payment), matching the distribution frequency.

BRKRP Dividends CAGR Chart

Bruker Corporation (BRKRP)

BRKRP Dividend Yield

Full Dividend Yield page

Dividend Yield

BRKRP Dividend Yield Chart

2.77%

Reported quarterly values; no daily interpolation.

+1.3pp over Max

Annual Dividend History(payment-date basis)

Year	Dividend/Share	YoY Growth
2026(YTD)	$11.96	Not comparable
2026	$11.96	N/A
2025	$3.67	N/A

Quarterly Dividend History

Quarter	Dividend/Share	YoY Growth
Q3 2026	$3.98	N/A
Q2 2026	$3.99	N/A
Q1 2026	$3.98	N/A
Q4 2025	$3.67	N/A

Dividend Yield Metrics

Current Yield: 3.35%
Average Yield (TTM): 2.35%
Average Yield (3Y): < 3Y history
Forward Yield on Cost (3Y): < 3Y history
Forward Yield on Cost (5Y): < 5Y history
Forward Yield on Cost (10Y): < 10Y history

Payout Ratio Analysis

Payout Ratio (Current): N/A
FCF Payout Ratio: 2526.93%
Payout Ratio (3Y Avg): < 3Y history
Payout Ratio (5Y Avg): < 5Y history
FCF Payout (3Y Avg): < 3Y history
FCF Payout (5Y Avg): < 5Y history

An FCF payout above 100% means dividends exceeded the period's free cash flow, often because of temporarily depressed FCF (one-off capex or working-capital swings) rather than an unfunded dividend. Compare against the earnings payout ratio and the multi-year trend before drawing a conclusion.

Dividend Coverage

Payout Ratio

N/A

Dividends / net income

FCF Payout Ratio

2526.9%

Dividends / free cash flow

Consecutive Years

N/A

Consecutive years of dividend increases

5Y Dividend Growth

N/A

Compound annual dividend growth

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Billerica, MA

11,085 employees

www.bruker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Frank H. Laukien

View full financials